Literature DB >> 14715019

Investigation of the degradation mechanisms of poly(malic acid) esters in vitro and their related cytotoxicities on J774 macrophages.

Maria Elisa Martinez Barbosa1, Sandrine Cammas, Martine Appel, Gilles Ponchel.   

Abstract

Poly(beta-malic acid) hydrophobic derivatives are promising polymers for biomedical and pharmaceutical applications. The objectives of the present work were to study the in vitro degradation profile of three PMLA hydrophobic derivatives and to evaluate their cytotoxicity before and after degradation. For this purpose, nanoparticles from poly(benzyl-malate) (PMLABe), poly(hexyl-malate) (PMLAHe), and poly(malic acid-co-benzyl-malate) (PMLAH/He) were prepared for degradation studies on standardized materials. Size exclusion chromatography (SEC) and 1H NMR indicated that degradation occurred by random hydrolysis of the polymer main chain for all three polymer derivatives. The presence of carboxyl groups on the side chain and their esterification with different alcohols varying hydrophilicities could affect the degradation rate. It was postulated that the degradation depended on the rate of diffusion of water into the core of the particles. The cytotoxicity of the polymer nanospheres as well as their degradation products were evaluated in vitro with J774 A1 murine macrophage-like cell line. The cytotoxicity depended on the degradation rate of the polymers and the amount of degradation products of low molecular weight produced.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14715019     DOI: 10.1021/bm0300608

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  7 in total

1.  Modification of Microbial Polymalic Acid With Hydrophobic Amino Acids for Drug-Releasing Nanoparticles.

Authors:  Alberto Lanz-Landázuri; Montserrat García-Alvarez; José Portilla-Arias; Antxon Martínez de Ilarduya; Eggehard Holler; Julia Ljubimova; Sebastián Muñoz-Guerra
Journal:  Macromol Chem Phys       Date:  2012-08-14       Impact factor: 2.527

2.  Nanoparticles of esterified polymalic acid for controlled anticancer drug release.

Authors:  Alberto Lanz-Landázuri; José Portilla-Arias; Antxon Martínez de Ilarduya; Montserrat García-Alvarez; Eggehard Holler; Julia Ljubimova; Sebastián Muñoz-Guerra
Journal:  Macromol Biosci       Date:  2014-06-06       Impact factor: 4.979

3.  Nanoconjugate Platforms Development Based in Poly(β,L-Malic Acid) Methyl Esters for Tumor Drug Delivery.

Authors:  José Portilla-Arias; Rameshwar Patil; Jinwei Hu; Hui Ding; Keith L Black; Montserrat García-Alvarez; Sebastián Muñoz-Guerra; Julia Y Ljubimova; Eggehard Holler
Journal:  J Nanotechnol       Date:  2010

4.  New functional degradable and bio-compatible nanoparticles based on poly(malic acid) derivatives for site-specific anti-cancer drug delivery.

Authors:  Zhi Wei Huang; Véronique Laurent; Ghizlane Chetouani; Julia Y Ljubimova; Eggehard Holler; Thierry Benvegnu; Pascal Loyer; Sandrine Cammas-Marion
Journal:  Int J Pharm       Date:  2011-04-27       Impact factor: 5.875

5.  Poly(methyl malate) nanoparticles: formation, degradation, and encapsulation of anticancer drugs.

Authors:  Alberto Lanz-Landázuri; Montserrat García-Alvarez; José Portilla-Arias; Antxon Martínez de Ilarduya; Rameshwar Patil; Eggehard Holler; Julia Y Ljubimova; Sebastián Muñoz-Guerra
Journal:  Macromol Biosci       Date:  2011-07-25       Impact factor: 4.979

6.  Novelty in the development of biodegradable polymer coatings for biomedical devices: paclitaxel grafting on PDMMLA derivatives.

Authors:  Elnaz Gholizadeh; Meriem Naim; Rima Belibel; Hanna Hlawaty; Christel Barbaud
Journal:  Des Monomers Polym       Date:  2022-03-20       Impact factor: 2.650

Review 7.  Polymalic acid for translational nanomedicine.

Authors:  Xing Huang; Liusheng Xu; Hui Qian; Xinghuan Wang; Zhimin Tao
Journal:  J Nanobiotechnology       Date:  2022-06-21       Impact factor: 9.429

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.